newsfilter
← Latest News
PR Newswire·

YS Biopharma Co., Ltd. to Hold Extraordinary General Meeting on December 28, 2023

YS

YS Biopharma Co., Ltd. ("YS Biopharma" or the "Company") (NASDAQ: YS), a global biopharmaceutical company, today announced that upon the receipt of a ...